These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12439660)

  • 1. The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?
    Chowdhury TA; Hopkins D; Dodson PM; Vafidis GC
    Eye (Lond); 2002 Nov; 16(6):689-93. PubMed ID: 12439660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema.
    Gupta A; Gupta V; Thapar S; Bhansali A
    Am J Ophthalmol; 2004 Apr; 137(4):675-82. PubMed ID: 15059707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic maculopathy and lipid-lowering therapy.
    Misra A; Vikram NK; Kumar A
    Eye (Lond); 2004 Jan; 18(1):107-8. PubMed ID: 14707990
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic retinopathy and serum lipids.
    Su DH; Yeo KT
    Singapore Med J; 2000 Jun; 41(6):295-7. PubMed ID: 11109348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of and underlying medical conditions in patients with diabetic exudative maculopathy.
    Dodson PM; Gibson JM
    Eye (Lond); 1991; 5 ( Pt 6)():699-703. PubMed ID: 1800169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids, diabetic maculopathy, and cardiovascular risk.
    Gandhi JS
    Eye (Lond); 2004 Jan; 18(1):108-9. PubMed ID: 14707991
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid-lowering therapy in patients with type-2 diabetes mellitus].
    Pados G; Audikovszky M
    Orv Hetil; 2003 Mar; 144(12):557-61. PubMed ID: 12723526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laser treatment of diabetic maculopathy].
    Giovannini A; Costantini G; Amato GP; Bottazzi M
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):358. PubMed ID: 3807230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment gap in the use of lipid-lowering drug therapy in diabetes: a population-based study.
    James P; Tan HH; MacAlpine R; Brennan G; Emslie-Smith A; Morris AD
    Diabet Med; 2004 Oct; 21(10):1108-12. PubMed ID: 15384958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology, pathogenesis and therapy of diabetic retinopathy and maculopathy].
    Jochmann C; Hammes HP
    Z Arztl Fortbild Qualitatssich; 2002 Mar; 96(3):167-74. PubMed ID: 12017760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.
    Klein R; Klein BE; Tomany SC; Cruickshanks KJ
    Ophthalmology; 2003 Jun; 110(6):1273-80. PubMed ID: 12799274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?
    Dodson PM
    Eye (Lond); 2009 May; 23(5):997-1003. PubMed ID: 19169236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of dyslipidaemia with macular oedema and hard exudates in diabetic maculopathy.
    Golubovic-Arsovska M
    Prilozi; 2007 Dec; 28(2):149-60. PubMed ID: 18356786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic retinopathy: more patients, less laser: a longitudinal population-based study in Tayside, Scotland.
    Vallance JH; Wilson PJ; Leese GP; McAlpine R; MacEwen CJ; Ellis JD
    Diabetes Care; 2008 Jun; 31(6):1126-31. PubMed ID: 18346993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipids in type 2 diabetes.
    Laakso M
    Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipids--diagnosis and therapy in type 2 diabetes].
    Wascher TC
    Acta Med Austriaca; 2004; 31(5):168-9. PubMed ID: 15747990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of dyslipidemia in the high-risk patient.
    Stein EA
    Am Heart J; 2002 Dec; 144(6 Suppl):S43-50. PubMed ID: 12486415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.
    Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(5):1019-21. PubMed ID: 16188392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipids, lipid-lowering drugs, and the risk of breast cancer.
    Eliassen AH; Colditz GA; Rosner B; Willett WC; Hankinson SE
    Arch Intern Med; 2005 Oct; 165(19):2264-71. PubMed ID: 16246993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.